Background: Heart failure (HF) is a chronic and incapacitant disease with bad prognosis, and it is commonly related to psychosocial comorbidities that difficult treatment adhesion. The prevalence of depression in HF varies from 20 to 40%, occurring 3 to 5 times more frequently in patients with HF than general population. The coexistence of depressive symptoms depreciates heart condition in patients with HF: depressive symptoms predict mortality, re-hospitalization, and an augment of symptoms in those patients. Aiming to clarify certain aspects of this comorbidity, it was performed a systematic review using Scopus and MEDLINE/PubMed databases, correlating HF and depression,
Introduction
Approximately 2% of general population suffer from Heart Failure (HF). This incidence is higher for 1 among 10 people with over than 75 years old (Lundgren et al., 2015; McMurray et al., 2012a) .
Despite treatment advances, HF has high morbidity and mortality rates, as well as leads to repetitive hospital admissions (Bekelma et al., 2014; Jaarsma et al., 2000) . Mortality rate in 5 years is 50% for recently diagnosed patients, in the last 20 years (Greene et al., 2015; Kemper, Carmin, Metha & Binkley, 2016) .
HF is a complex clinical syndrome characterized by dyspnea and fatigue, and evidences subjacent structural abnormality or cardiac dysfunction (McMurray et al., 2012b; Tully, Selkow, Bengel & Rafanelli, 2015) . It is a chronic and incapacitant disease, with bad prognosis and a severely prejudiced quality of life (Bleumink et al., 2004; Lossnitzer et al., 2015) . Other studies (Adams et al., 2005; Chamberlain et al., 2015; Kemper et al., 2016) add that many times HF is accompanied by other psychosocial comorbidities that difficult treatment adhesion.
Facing this, Tully et al. (2015) highlight that is common the prevalence of depression in HF. Some studies show a prevalence varying from 20 to 40% (Johansson, Dahlstrom & Brostrom, 2006; Lundgren et al., 2015; Rutledge, Reis, Linke, Greenberg & Mills, 2006) . According other data, Gelbrich et al. (2014) and Rutledge et al. (2006) depression occur 3 to 5 times more frequently in patients with HF than the general population, depending on symptoms severity of HF and comorbidities.
Interrelation between depressive symptoms and adverse cardiac outcome is firmly stablished (Gelbrich et al., 2014) . Studies (Jiang et al., 2001; Jünger et al., 2005; Lossnitzer et al., 2015) corroborate this idea, once the coexistence of depressive symptoms depreciates heart condition in patients with HF: depressive symptoms predict mortality, re-hospitalization, and an augment of symptoms in those patients. Besides, depression is associated to higher health costs, significantly harms quality of life, has negative impacts in disease management strategies and is associated to lower rates of treatment adhesion (Bekelma et al., 2015; Huffman et al., 2014; Tully et al., 2015) .
In this sense, recent researches are more and more focused in effects of depression treatment in patient with HF (Dekker, 2011; Lossnitzer et al., 2015; Thombs et al., 2008) . Many studies report positive effects to several non-pharmacological depression treatments in patients with HF (Dekker, Moser, Peden & Lennie, 2012; Lossnitzer et al., 2015; Rutledge et al., 2006; Thombs et al., 2008) . Some researches also encountered an improvement of cardiac outcomes and clinical symptoms, as consequence of depression treatment (Dekker et al., 2012; Lossnitzer et al., 2015; Sullivan et al., 2009) Thus, this paper aimed to answer the following question: How to manage a patient with heart failure and depression? For that, a systematic review of the studies approaching this theme was performed, in order to show the best methods that can manage this comorbidity, and how these methods are applied in clinical practice.
Method
This is a systematic review following Cochrane Handbook and Meta-Analyzes (PRISMA) guidelines recommendations for conduction the systematic review. Previously chosen inclusion/exclusion criteria were adopted to analyze data present in Scopus and MEDLINE/PubMed databases, due their data coverage regarding heart failure and depression.
The search was conducted from January 1, 2013, to August 20, 2017, by means of the descriptors found in MeSH: "heart failure" and "depression". Also, after a brief analyzes of what word must be used to successfully gather the full information required in our search, the keyword "management" was used. Data screening applied combinations and gray literature, as follows: #1. "Heart Failure" [MeSH Terms]; #2. "Depression" [MeSH Terms]; #3. "Management" [Keyword] , using the following research strategy: (#1 AND #2) AND #3.
The formulation of the research question was structured based on the PICO acronym. Each word of the PICO component means: P: patients diagnosed with heart failure and depression; I: management methods applied; C: collection of the available scientific information from January 1, 2013 to August 20, 2017; O: gather reliable information to correctly orientate health professionals when dealing with this kind of patient. The research question consists in: "How is the correct management of patients with diagnosed heart failure and depression?" The following types of studies were included: Case Reports, Clinical Study, Clinical Trial, Comparative Study, Controlled Clinical Trial, Evaluation Studies, Journal Article, Multicenter Study, Observational Study, Randomized Controlled Trial, Twin Study, whose main theme was management of patients with heart failure and depression, in English language. This search period was chosen to gather the most recent information regarding the management of these patients, aiming to recover the most updated data and to build a consistent analysis. Exclusion criteria were comprised of articles that did not directly approach the management of patients with diagnosed heart failure and depression, studies that did not have the open access availability to full text and studies with different type of design. Studies were chosen through electronic search in Scopus and MEDLINE/PubMed databases.
Throughout the process of study selection, two reviewers worked independently and analyzed the studies to be included. When there was a disagreement between them, a third reviewer was used to make the final assessment on the inclusion or non-inclusion of the study. The entire content of the chosen studies was analyzed.
Results
Based on research strategy, 209 publications were identified at MEDLINE and 316 at Scopus, resulting in 525 publications. After an analysis of the title, abstract and body of the remaining references based on inclusion criteria of the study, 508 articles were excluded, and 17 studies remained in final sample. Repeated articles were computed only once in the final counting.
Figure 1 (flow diagram) presents an overview of the studies included in the final table and the elements used in the analysis process. Also, Table 1 shows an overview of selected articles as well as their main findings, methods of control and data publication KalterLeibovici O. et al. [33] 2017 Disease management in the treatment of patients with chronic heart failure who have universal access to health care: A randomized controlled trial BMC Medicine In this multicenter open-label trial, 1,360 patients recruited after hospitalization for heart failure exacerbation (38%) or from the community (62%) were randomly assigned to either disease management or usual care.
Patients assigned to disease management had a better health-related quality of life and a lower depression score during follow-up. This comprehensive disease management intervention was not superior to usual care with respect to the primary composite endpoint, but it improved health-related quality of life and depression.
Scopus The patients assigned to usual care were evaluated by the cardiologists at the heart failure centers every 6 months during follow-up, thus some contamination of the control intervention may be possible. In addition, the follow-up assessments of the patients' NYHA classification and 6-minute walk test were performed by assessors who were not blinded to the patients' assigned intervention. There were no significant differences in baseline characteristics between patients randomized to the PCDM intervention (n = 187) vs usual care (n = 197); Among those who screened positive for depression, there was a greater improvement in the Patient Health Questionnaire 9 scores after 1 year in the intervention arm than in the usual care arm (2.1 points lower, P =.01). There was no significant difference in 1-year hospitalization rates between the intervention arm and the usual care arm (29.4%vs 29.9%, P =.87)
Scopus There are several limitations to this study. We were unable to blind participants to the intervention. Because the study was conducted among the population of US veterans, the results may not be generalizable to other health systems and populations. Additional data on aspects of implementation of the intervention may have informed why the intervention did not improve health status compared with usual care.
Lossnitzer N et al. [14] 2015 A patientcentered perspective of treating depressive symptoms in chronic heart failure: What do patients prefer?
Patient Educ
Couns.
85 patients with CHF fulfilling the criteria of a depressive disorder according to the PHQ-9 were investigated
The most favored treatment option (64.7%) was 'regular supportive talks' -concerning topics such as quality of life, financial stressors, overall health, and/or social relationships -ideally in conjunction with appointments in the CHF Outpatient Department. Furthermore, our interviewed patient sample was very interested in heart-failure education groups: 55.3% reported that they would accept such an offer. 42.4% (n = 36) intended to utilize a treatment at the first assessment; 24.7% (n = 21) actually utilized a treatment after the three month follow-up. The most utilized treatments were 'regular supportive talks' (n = 14) and 'heartfailure exercise group' (n = 4).
Pubmed First, our patient-sample was recruited from a CHF outpatient department and may therefore not be representative of CHF patients recruited from the general population or of those in primary care [33] . Second, our participation rate was only 67%. Third, we included only those variables with p < .05 in the final multivariate regression analyses. Some variables may have been omitted on the basis of this criterion which could have been important in combination with another predictor.
Lundgren J et al. [2] 2015 Internet-based cognitive behavior therapy for patients with heart failure and depressive symptoms: A proof of concept study.
Seven HF patients with depressive symptoms were recruited to the study.
Based on research in HF and CBT, a nine-week program was developed. The median depression score decreased from baseline to the end of the study (PHQ-9: 11-8.5; MADRS-S: 25.5-16.5) and none of the depression scores worsened. Feedback from health care providers required approximately 3h per patient. Facilitating perceptions (e.g. freedom of time) and demanding perceptions (e.g. part of the program demanded a lot of work) were described by the patients.
Pubmed The patients in the study had to make an active choice to become eligible for participation (reading the advertisement and actively going to the study website to register). Hence, there may be a sample bias in that patients with no access to the internet, low computer-skills, or no access to newspapers were not included. Furthermore, the mean age of our population was younger than the general HF population. There was no evidence of a difference between the groups in whether or not a patient was re-admitted to hospital during the 12 month follow-up period (p=0.66). There was no evidence of a difference between the treatment groups in the mean MLHF scores over time (p=0.768), the European self-care questionnaire (p=0.340) or the mean HAD anxiety score (p=0.786). However, when adjusted for baseline scores the self-management group had a statistically significant higher HADS depression score at 12 months (p=0.003).
Pubmed One limitation to the study is that control patients may have asked the heart failure nurse for help in following the manual, which may have contaminated the control group. It may also be that the self-management was not of sufficient duration or intensity. The composite endpoint of mortality and re-hospitalization was neutral overall and in all subgroups. However, HNC reduced mortality risk in both depressed and nondepressed patients [adjusted hazard ratios (HRs) 0.12, 95% confidence interval (CI) 0.03-0.56, P = 0.006, and 0.49, 95% CI 0.25-0.93, P = 0.03, respectively], but not in PHQdeniers (HR 1.74, 95% CI 0.77-3.96, P = 0.19; P = 0.006 for homogeneity of HRs). Average frequencies of patient contacts in the HNC arm were 12.8 ± 7.9 in non-depressed patients, 12.4 ± 7.1 in depressed patients, and 5.5 ± 7.2 in PHQ-deniers (P < 0.001). Early after decompensation, HNC reduced mortality risk in non-depressed and even more in depressed subjects, but not in PHQdeniers.
Pubmed We studied patients only in the first 180 days after an episode of acute cardiac decompensation for systolic HF, our results can be generalized neither to stable patients with chronic systolic HF nor to patients with HF and preserved LVEF. Another limitation concerns comparability of the depressed subgroups discussed in our study. In none of these studies was the diagnosis based on DSM-IV criteria. We found that ongoing PC support beyond the initial PC consultation resulted in greater reductions in symptom burden, including pain and depression, confirming that on-going PC provides clinicians with the opportunity to focus on the needs and preferences of greatest importance to patients and families are more likely to result in better outcomes.
Scopus First, as expected with descriptive, exploratory studies, causation cannot be inferred. We cannot say that the number of PC referrals actually resulted in reduced symptom burden. Second, the generalizability of our findings is limited because the sample is from a single university affiliated medical center; patients were younger on average compared to patients with HF in the community. Third, we did not have a mechanism to verify the time spent on individual PC services during the follow-up visits. Last, our study did not have a control group. 2014 Clinical and psychological telemonitoring and telecare of high risk heart failure patients.
J Telemed
Telecare.
Eighty patients were randomized before hospital discharge to a usual care group (n¼40: follow up at the outpatient clinic) or to an integrated management group (n¼40: patients learned to use a handheld PDA and kept in touch daily with the monitoring centre). At enrolment, the groups were similar for all clinical variables.
At one-year follow-up, integrated management patients showed better adherence, reduced anxiety and depression, and lower NYHA class and plasma levels of BNP with respect to the usual care patients (e.g. NYHA class 2.1 vs 2.4, P<0.02). In heart failure patients at high risk of relapse, the regular acquisition of simple clinical information and the possibility for the patient to contact the clinical staff improved drug titration, produced better psychological status and quality of life, and reduced hospitalizations for heart failure.
Pubmed First, telemonitoring does not imply telecare: this may explain the failure of ambitious, multicentre studies and the better results of local experiences, where patients are likely to benefit from individual interaction with dedicated, well-trained and specialized care providers. Second, a range of different variables has been used in telemonitoring: remote checking of bodyweight, blood pressure, heart rate, even natriuretic peptides, have all been tested to prevent hospital admissions Study patients represent a very small number of the patient panels of a given primary care provider, and thus the potential for contamination is low. The intervention is multimodal, and we may not know the most important components of the intervention if it is successful. et al. [39] 2013 Early e experience of a pilot intervention for patients with depression and chronic medical illness in an urban ACO Patients with a HF diagnosis at four VA Medical Centers were identified through population based sampling. Patients with a Kansas City Cardiomyopathy Questionnaire (KCCQ, a measure of HF-specific health status) score of < 60 (heavy symptom burden and impaired quality of life) were invited to enroll in the PCDM trial. Enrolled patients were randomized to receive usual care or the PCDM intervention.
The primary study outcome is change in overall KCCQ score. Secondary outcomes include depression, medication adherence, guideline-based care, hospitalizations, and mortality.
Pubmed Study patients represent a very small number of the patient panels of a given primary care provider, and thus the potential for contamination is low. The intervention is multimodal, and we may not know the most important components of the intervention if it is successful.
Discussion
Use of telephone calls aiming support and monitoring is extensively reported in literature, reaching satisfactory results in depression management and in general clinical symptoms (Huffman et al., 2014; Kalter-Leibovici et al., 2017; Piette et al., 2015) .
As an example of this, Chung et al. (2013) performed a pilot study through a telephone therapy program and obtained a regression of PHQ-9 (Patient Health Questionnaire 9) index in 15% of studied patients, corroborating the study of Gelbrich et al. (2014) in which patients were accompanied and evaluated through telephone regarding selfmonitoring, and were regularly encouraged to face individual problems. PHQ-9 is a nine items instrument self-administrated and projected to detect depression in different populations (Lundgren et al., 2015) . Results are shown as an effective strategy of management to HF depressed patients, once they significantly improved surviving during first 180 days after discharge from hospital. Piette et al. (2015) also demonstrated the use of interactive telephonic calls, in which patients received personalized counseling about self-management. Among patients with higher level of depressive symptoms participating the study, those randomized were the ones who reported an excellent or very good improvement in general health. Similar strategies were used by Kalter-Leibovici et al. (2017 ) Bekelman et al. (2013 and Villani et al. (2014) showed that the group that applied the management presented greater adhesion rates, clinical and psychological status improvement, recovering of relevant prognostic indexes, as ventricular function and BNP levels, and reduction of hospitalizations due heart failure. Favorable results were attributed to daily monitoring. Cognitive behavioral therapy in depression treatment, which can be through telephone, or group or individual therapy, also resulted in mental health improvement among HF patients (Tully et al., 2015) . In Huffman et al. (2014) study, during 24 weeks, the participants were randomized in a group that received cognitive behavioral intervention based on a phone call, trying to reach depressive and anxiety disorders, and in a control group, which had increased usual care. There was improvement in quality of life and mental health ), compared to groups using a random effect model. Patients who received cognitive behavioral intervention also had improvement in depressive symptoms and general functioning, obtaining higher treatment rates of a mental disorder. Kenealy et al. (2015) demonstrated that patients submitted to habitual care and encouraged to daily insert data in an electronic device had anxiety and depression levels significantly reduced, compared to patients from control group. Hospital admissions, days in hospital, visits to emergency department, ambulatorial visits and costs did not differ significantly among groups. Positive results were attributed to greater security and more care by the patient, and better family understanding about condition management. Bekelman et al. (2014) associated different aspects: nurse telephone calls with evaluation of structured symptoms, and guidelines to relieve shortness of breath, fatigue, pain, or depression; structured counseling through telephone aiming disease adjustment; and weekly team reunions with a specialist in palliative care, cardiologist and primary attention doctor focused on medical recommendations to primary care providers. These aspects are being evaluated, with promising initial results on quality of life, decreased hospitalizations, depression and anxiety. Duncan, Pozehl, Hertzog and Norman (2014) show the HEART Camp, a program that involves aerobic and anaerobic exercises, and a social cognitive therapy, which postulates that self-efficiency is derived from interrelation of behavior, cognition, and personal and environmental influence (Bandura, 1997; Duncan et al., 2014) . HEART Camp sample consisted of 42 patients randomized in two groups and the feedback was composed by weekly graphic of participation in exercise (frequency, duration, intensity). This study did not found differences in humor for exercise group and control group, after some time. The research about exercise in cardiac population has reported improvement of psychological responses, more notably for depression and anxiety (Evangelista, Lião, Motie, Michelis, BallardHernandez & Lombardo, 2014) . Memory lack in states of humor can be reflex of a low frequency of group and the fact that these results are preliminary results.
The participation of a multidisciplinary team is present in most care programs aimed in patients with HF and depression. Psychologists, psychiatrics, nurses, doctors and professionals specialized in palliative care, when actuate together, promote security and a higher attention level, resulting in treatment quality improvement, as well as improvement of disease symptoms (Bekelma et al., 2014; Kalter-Leibovici, 2017; Kemper et al., 2016) .
Patient engagement is of total importance for treatment efficacy, Cockayne, Pattenden, Worthy, Richardson and Lewin (2014) and Evangelista et al. (2014) with an intervention based on palliative care, in which the specialist performed physical and psychosocial evaluation and discussions about care planning, and worked together with the participants to develop a treatment plan centered in patient and family, which improve the involvement of patients and their families in caring decisions. The continuous and centered support resulted in greater reductions in symptoms load, including pain and depression, confirming that palliative care offers to clinicians the opportunity to focus in needs and preferences of greater importance to patients and families, leading to better treatment results.
Pharmacological treatment with selective serotonin reuptake inhibitor seems to be safe for patients with cardiac insufficiency, Lundgren et al. (2015) and O´Connor et al. (2010) but the effect in depression remains uncertain (Lundgren et al., 2015; Woltz et al., 2012) . A great double blind study controlled by placebo, comprising 469 patients, did not show depression improvement in patients with HF after antidepressant use (Lossnitzer et al., 2015; O´Connor et al., 2010) .
Similar results were reported by some studies, Gelbrich et al. (2014) and Angermann et al. (2007) in which antidepressant did not show positive effects in patients with cardiovascular diseases and comorbid depression. Kemper KJ, et al. (2016) add to actual data that pharmacological intervention had uncomplete impact on stress and depression in patient with HF.
In other hand, Lossnitzer et al. (2015) reveal that many patients with HF have objection to antidepressant because they are concerned about adverse effects or negative interaction of medication. This is consistent to recent studies that suggest cardiovascular side effects of antidepressants in patients with HF (Lossnitzer et al., 2015; Tousoulis et al., 2010) . Still, this study reports vantages of successful psychotherapy compared to antidepressant pharmacotherapy in treatment of depression associated to HF.
In this context, new approaches are necessary to favor self-management and, thus, improve psychosocial and behavioral factors that affect quality of life in patients with HF (Kemper et al., 2016; Du et al., 2011) . The search for a correct treatment of cardiac insufficiency involved a great number of research groups, but, in reality, patients are still not treated as they should (Villani et al., 2014) .
Conclusion
Facing all analyzed data, one can infer that the best way to manage a patient with heart failure and depression is through the combination of pharmacological and non-pharmacological treatments. Nevertheless, psychotherapy, as cognitive behavioral therapy; self-management strategies; and palliative caring, allied to involvement of a multi-disciplinary team composed by doctors, nurses, psychologists, psychiatrists, and other professionals specialized in palliative caring, are, notably, the most effective way to manage this class of patient. On the other hand, information about pharmacological interventions applied in this context is still scarce, which impedes the formulation of a coherent answer to the question of this study.
Thus, the limitation of this study can be attributed to data lack about antidepressant efficacy in patients with HF, as well as other studies show (Gottlieb et al., 2007; Lesperánce et al., 2003; Lossnitzer et al., 2015; O'Connor et al., 2010) . This efficacy was approached in some selected studies, but it was partially investigated, remaining uncertain the antidepressant effects in HF. Thus, new researches that aims to evaluate the correct management of HF associated to depression, combining psychosocial and pharmacological interventions, are necessary. Vol. 11 No. 42 doi: 10.3823/2583 
